Reassortment of Bunyavirus in ticks and animal models
Reassortment of Bunyavirus in ticks and animal models
批准号:
10686796
负责人:
Jae U Jung
金额:
$57.78万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-19 至 2027-07-31
关键词:
4 year oldAffectAgeAnimal ModelAnimalsAntigenic VariationArbovirusesAsiaAttenuated Live Virus VaccineBasic ScienceBiological AssayBloodCNR1 geneCell Culture TechniquesCellsCharacteristicsClinicalCommunicable DiseasesCoxiellaDNA VaccinesDangerousnessDiseaseEmergency SituationEpidemicFar EastFatality rateFemaleFerretsFeverFutureGenesGeneticGenetic ProcessesGenetic RecombinationGenomeGenotypeGlycoproteinsGoalsHaemaphysalis longicornisHeartland virusHumanIFNAR1 geneImmunocompetentIn VitroInfectionInterferonsLarvaMammalsMediatingMethodsMidgutModelingMusNatureNymphOrthobunyavirusOvaryPathogenesisPathogenicityPatientsPhenotypeRNARNA VirusesRisk FactorsRoleSalivarySalivary GlandsSevere Fever with Thrombocytopenia Syndrome VirusSymptomsSyndromeSystemTestingThrombocytopeniaTicksTimeViralViral PathogenesisVirusVirus DiseasesVirus-like particleage relatedagedclimate changeclinical applicationclinical diagnosisco-infectioneggfeedingfitnessimmunogenicityin vivoinsightinterferon alpha receptormortalitymouse modelneutralizing antibodynovelolder patientoutbreak concernpathogenpathogenic virusreverse geneticssymbionttick feedingtick-bornetick-borne virustooltransmission processvectorviral fitnessviral transmission
中文摘要
项目摘要/摘要
被列为世卫组织最危险的九种病原体之一,SFTSV迅速具有12%-30%的病死率
通过虱子与动物/人、人与人和动物与人之间的传播,并诱导
以血小板减少为特征的免疫性疾病。病毒的重新分类是一个过程
一种基因重组,这种基因重组是节段式RNA病毒所独有的,在这种病毒中,一个细胞同时感染
携带多个病毒的自然宿主和载体的组合可能导致基因片段的洗牌
用新的基因组组合产生后代病毒。重新排序对病毒有很大影响
适合性,并直接影响抗原变异,混淆了现有的病毒控制方法。在……里面
在这个应用中,我们将检验扁虱介导的SFTSV感染的自然过程和
重组引入了适应性、遗传性、抗原性或致病性的表型变化。
变成了后代的重新组合。这项研究的目的是演示SFTSV的自然过程
体外感染和重组对适合性、免疫原性、传播性和致病性的影响
活体动物模型和长角毛滴虫,最终将基础研究与临床联系起来
申请。
英文摘要
Project Summary/Abstract
Listed in the WHO top nine most dangerous pathogens, SFTSV has 12-30% fatality rates, rapidly
spreads through tick-to-animal/human, human-to-human and animal-to-human and induces
immunopathogenic disease with a characteristic thrombocytopenia. Virus reassortment is a process
of genetic recombination that is exclusive to segmented RNA viruses in which co-infection of a cell
of natural host and vector with multiple viruses may result in the shuffling of gene segments to
generate progeny viruses with novel genome combinations. Reassortment greatly affects virus
fitness and directly influences antigenic variation, confounding available methods of virus control. In
this application, we will test the hypothesis that tick-mediated natural course of SFTSV infection and
reassortment introduces phenotypic changes of fitness, transmissibility, antigenicity, or pathogenicity
into progeny reassortants. The goal of this study is to demonstrate the natural course of SFTSV
infection and reassortment for fitness, immunogenicity, transmissibility, and pathogenesis in in vitro
and in vivo animal models and H. longicornis ticks, ultimately bridging basic research to clinical
application.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Infant Immunologic and Neurologic Development following Maternal Infection in Pregnancy during Recent Epidemics
-
批准号:10784250
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2023
-
负责人:Jae U Jung
-
依托单位:
Reassortment of Bunyavirus in ticks and animal models
-
批准号:10512873
-
项目类别:
-
资助金额:$59.31万
-
财政年份:2022
-
负责人:Jae U Jung
-
依托单位:
KSHV Epigenetic Regulation
-
批准号:10293613
-
项目类别:
-
资助金额:$43.12万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
KSHV Epigenetic Regulation
-
批准号:10312714
-
项目类别:
-
资助金额:$43.12万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor
-
批准号:10413218
-
项目类别:
-
资助金额:$49.09万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Tickborne SFTS Virus Vaccine Development
-
批准号:10670989
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
KSHVmediated regulation of proline metabolism
-
批准号:10293612
-
项目类别:
-
资助金额:$47.91万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Tickborne SFTS Virus Vaccine Development
-
批准号:10227961
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Tickborne SFTS Virus Vaccine Development
-
批准号:10451811
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor
-
批准号:10643706
-
项目类别:
-
资助金额:$49.09万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Regulation of lymphangiogenesis by KSHV vIRF3
-
批准号:10252172
-
项目类别:
-
资助金额:$12.43万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
KSHVmediated regulation of proline metabolism
-
批准号:10312715
-
项目类别:
-
资助金额:$46.3万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
KSHV Epigenetic Regulation
-
批准号:10252377
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
KSHVmediated regulation of proline metabolism
-
批准号:10267964
-
项目类别:
-
资助金额:$18.84万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor
-
批准号:10030628
-
项目类别:
-
资助金额:$49.09万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
KSHVmediated regulation of proline metabolism
-
批准号:10521249
-
项目类别:
-
资助金额:$46.22万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
KSHV Epigenetic Regulation
-
批准号:10521293
-
项目类别:
-
资助金额:$43.12万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor
-
批准号:10254390
-
项目类别:
-
资助金额:$49.09万
-
财政年份:2020
-
负责人:Jae U Jung
-
依托单位:
SFTSV nonstructural protein NSs-mediated immunopathogenesis
-
批准号:10441349
-
项目类别:
-
资助金额:$60.42万
-
财政年份:2018
-
负责人:Jae U Jung
-
依托单位:
Infection and Rapid Transmission of SARS-C0V-2 in Ferrets
-
批准号:10369137
-
项目类别:
-
资助金额:$53.3万
-
财政年份:2018
-
负责人:Jae U Jung
-
依托单位:
海外基金